ask="6.75"
ask_size="1000"
average_daily_volume="913719"
bid="5.01"
bid_size="100"
book_value="0.05"
change="+0.38"
change_from_200_day_moving_average="1.00"
change_from_50_day_moving_average="-0.01"
change_from_52_week_high="-1.40"
change_From_52_week_low="4.53"
change_in_percent="+6.57%"
close="6.16"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.93"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.86"
ex_dividend_date="N/A"
float_shares="42554000"
high="6.17"
high_52_weeks="7.56"
last_trade_date="2/15/2017"
last_trade_price="6.16"
last_trade_size="33122"
last_trade_time="4:00pm"
low="5.75"
low_52_weeks="1.63"
market_capitalization="454.35M"
moving_average_200_day="5.16"
moving_average_50_day="6.17"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="6.50"
open="5.77"
pe_ratio="N/A"
peg_ratio="-0.32"
percent_change_from_200_day_moving_average="+19.29%"
percent_change_from_50_day_moving_average="-0.17%"
percent_change_from_52_week_high="-18.52%"
percent_change_from_52_week_low="+277.91%"
previous_close="5.78"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="107.04"
price_per_sales="19.40"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="8.88"
stock_exchange="NMS"
symbol="BCRX"
volume="1123309"
weeks_range_52="1.63 - 7.56"
